INTRODUCTION

Epigenetic regulation through histone acetylation is essential for proper growth and development, and its role in human genetic diseases is increasingly recognized. KAT6B (formerly known as MYST4 and MORF) encodes a highly conserved histone acetyltransferase that is part of the MYST family1 and regulates the expression of multiple genes.2 Previous work has demonstrated that KAT6B preferentially acetylates lysine 14 of histone H3.2,3 KAT6B functions in a multisubunit complex with other proteins including KAT6A, BRPF1, and ING5.4 Exome sequencing has enabled identification of de novo heterozygous variants in KAT6B as the etiology of both genitopatellar syndrome (GPS) (OMIM 606170) and Say–Barber–Biesecker–Young–Simpson syndrome (SBBYSS) (OMIM 603736), a variant of Ohdo syndrome.5,6,7

GPS is a skeletal dysplasia characterized by hypoplastic or absent patellae, flexion contractures of the hips and knees, agenesis of the corpus callosum, microcephaly, craniofacial dysmorphisms, and genitourinary anomalies.8 Ohdo syndrome was first described as a genetic condition characterized by intellectual disability in association with congenital heart disease and dysmorphisms.9 Subsequently, Young and Simpson reported a more severe phenotype later referred to as the SBBYS variant of Ohdo syndrome, or SBBYS syndrome.10,11,12 SBBYSS is characterized by blepharophimosis, dacryostenosis, ptosis, a mask-like facial appearance, and long thumbs/great toes.5 GPS and SBBYSS have been historically described as distinct disorders with respect to clinical findings but with several overlapping features. Indeed, both the GPS and SBBYSS phenotypes include significant global developmental delay/intellectual disability, hypotonia, genital abnormalities, patellar hypoplasia/agenesis, congenital heart defects, dental anomalies, hearing loss, and thyroid anomalies.13 To date, about 90 individuals with KAT6B disorders have been reported, including 18 with GPS, 58 with SBBYSS, and 13 described as having an intermediate phenotype.

The KAT6B pathogenic variant spectrum from previously published individuals includes 56 variants: 22 substitutions, 22 small intragenic deletions, 10 small intragenic duplications, and 2 small intragenic deletions associated with an insertion. The types of variants at the protein level include 33 frameshift, 19 nonsense, 2 missense, and 2 splicing defects. Pathogenic variants are most often located in exon 18, the last exon of the gene. More proximal pathogenic variants have typically been associated with milder phenotypes and are thought to lead to nonsense-mediated decay (NMD) and KAT6B haploinsufficiency.5 Premature termination codons in the last exon or the last 50 nucleotides of the penultimate exon typically cause the messenger RNAs (mRNAs) to escape the NMD pathway and be translated into aberrant proteins with either loss- or gain-of-function effects.14,15 Interstitial 10q21.3q22.2 deletions encompassing KAT6B have been reported in eight individuals who presented with some features overlapping with KAT6B disorders, such as hypotonia, developmental delay, feeding difficulties, and craniofacial dysmorphisms.16 Of note, Preiksaitiene et al. reported a 5-Mb 10q22.1q22.3 deletion encompassing KAT6B in an individual with blepharophimosis, minor dysmorphisms, and developmental delay, compatible with SBBYSS.17 Through genotype–phenotype correlation studies, we observed that pathogenic variants causing the more severe GPS phenotype were located proximally in exon 18 and could lead to the expression of a truncated protein lacking the C-terminal domain. A gain-of-function effect was hypothesized to occur from altered binding affinity or dysregulated interactions of KAT6B with interacting proteins leading to clinical findings more specific to GPS,18 whereas the SBBYSS phenotype would result from a loss of KAT6B functions. This has not yet been tested experimentally. Recently, more proximal pathogenic variants in KAT6B exons 3, 7, 11, and 14–17 (for GPS, only in exons 17 and 18) were identified in individuals with GPS, SBBYSS, and the intermediate phenotype. The increasing identification of individuals with an intermediate phenotype having a variant previously identified in individuals with GPS or SBBYSS make phenotype predictions based on genotype imprecise.

KAT6B pathogenic variants almost always occurred de novo when parental testing has been performed. Recently, Kim et al. reported a family with an inherited pathogenic variant in exon 11 causing relatively mild disease in three individuals with SBBYSS.19 Another inherited pathogenic splice variant in intron 5 has been found in six related individuals with mild SBBYSS phenotypes.20 GPS and SBBYSS are thus part of a broad phenotypic spectrum and the variable expressivity of KAT6B disorders is being increasingly recognized, motivating research and delineation of an expanded allelic series.

Here, we review the clinical phenotypes of all reported individuals with molecularly confirmed KAT6B pathogenic variants in the literature and compare them with 32 newly identified individuals with GPS, SBBYSS, and intermediate phenotypes. We aim to better define the phenotypic spectrum of KAT6B disorders. We present 24 new KAT6B pathogenic variants and have updated a publicly accessible Leiden Open Variation Database (LOVD) KAT6B variant database (https://databases.lovd.nl/shared/genes/kat6b), which catalogs all known KAT6B pathogenic variants.

MATERIALS AND METHODS

Individuals with molecularly proven KAT6B disorders from different clinical centers were included in this series. Some individuals presented with clinical features suggestive of a KAT6B disorder and underwent targeted KAT6B sequencing. Molecular analysis via Sanger sequencing in these cases was performed at Baylor College of Medicine (Houston, TX, USA) or at Sainte-Justine Hospital Research Center (Montreal, QC, Canada).6 This study was approved by the CHU Sainte-Justine Institutional Review Board. Other individuals underwent exome sequencing (ES) as part of research projects involving patients with suspected rare Mendelian genetic conditions. However, KAT6B variants for most individuals were identified by clinical testing performed in commercial laboratories (panel or ES). These individuals have been enrolled in the present study following the discovery of a KAT6B pathogenic variant, through communication between clinical teams. Others have been recruited through Matchmaker Exchange21 and GeneMatcher.22 Details about the sequencing technique used for each individual are presented in Table S1. Information was uniformly obtained from each clinical team using a structured phenotypic table (Table S2). Each individual from this cohort was evaluated regarding the presence of major features suggestive of GPS or SBBYSS (Table 1) and the patients were subdivided in the following four different clinical subtypes (Table S3):

  1. 1.

    KAT6B disorder, GPS subtype (at least two major features suggesting GPS)

  2. 2.

    KAT6B disorder, SBBYSS subtype (at least two major features suggesting SBBYSS)

  3. 3.

    KAT6B disorder, intermediate subtype (at least two major features of both GPS and SBBYSS, excluding patellar anomalies)

  4. 4.

    KAT6B disorder, subtype not otherwise specified (cannot be classified in subtypes 1, 2 or 3)

Table 1 Major clinical features suggestive of GPS and SBBYSS.
Full size table

Literature search was conducted in PubMed using the key words KAT6B, SBBYSS, and GPS, with the last query on November 20th, 2019. The identification of all published KAT6B variants was assisted by the LOVD KAT6B database.

Informed consent to publish individuals’ clinical information and photographs was obtained from the parents of the individuals reported in this article.

RESULTS

We present the clinical features and pathogenic variants of 32 previously unreported individuals with KAT6B disorders, including 8 individuals with GPS, 15 with SBBYSS, 6 with the intermediate phenotype, and 3 with a KAT6B disorder not otherwise specified (Table 2). Representative photographs of some of these individuals are presented in Fig. 1. Our literature search identified 89 previously published individuals with a molecularly confirmed KAT6B disorder, and their clinical features are summarized in Table S4. The clinical manifestations are discussed below.

Table 2 Clinical features of 32 individuals with KAT6B disorders and frequency of these features in previously reported individuals.
Full size table
Fig. 1: Clinical photographs of 20 newly reported individuals with KAT6B disorders.
figure 1

(a) Facial features of affected individuals. Note the blepharophimosis, ptosis, and mask-like facies in individuals with SBBYSS and the intermediate phenotype. (b) Long thumbs and/or long great toes (upper left: individual 13; upper right: individual 15; lower left and lower right: individual 29). (c) Flexion contractures and club feet (left: individual 24; right: individual 5). (d) Absent patella in individual 5. (e) Preaxial polydactyly of the right hand in individual 25. (f) Overlapping toes in individual 21. (g) A newborn with GPS who died after birth at 28 weeks of gestation (individual 8). Note the high forehead, blepharophimosis, small palpebral fissures with hypertelorism, sparse eyebrows and eyelashes, small simplified ears with bilateral pits, proximal/distal arthrogryposis, and contractures of the hip/knees. GPS genitopatellar syndrome, NOS not otherwise specified, SBBYSS Say–Barber–Biesecker–Young–Simpson syndrome.

Full size image

Neurological findings

All eight individuals with GPS in this cohort had agenesis or hypoplasia of the corpus callosum; this is in keeping with the literature as it has been noted as a major neurologic feature of the GPS phenotype.23 Other common neurologic findings in all KAT6B disorders include microcephaly and axial and appendicular hypotonia. Six previously reported individuals and two from this cohort presented with seizures.13,24,25,26,27,28

Affected individuals, including the ones in this report, often present with other cerebral/neurological anomalies such as colpocephaly, hydrocephaly, dilated ventricles, or ventriculomegaly (11 individuals); pachygyria or simplification of cortical sulci (4 individuals); delayed white matter myelination or hypomyelination (4 individuals); and gray matter heterotopia (3 individuals).6,17,26,27,29,30,31,32 Each of the following anomalies were described in two individuals: periventricular gliosis, agenesis of the septum pellucidum, telencephalic or periventricular leukoencephalopathy, and hypertonia/dystonia; other anomalies were reported in only one individual each: cortical atrophy, agenesis of the anterior commissure, cerebral palsy, lenticulostriate vasculopathy, brainstem hypoplasia, unspecified cerebellar abnormalities, spina bifida, Horner syndrome, nonspecific gray matter differences, partial agenesis of the cingulate gyrus, and wide Virchow–Robin spaces.24,26,30,31,33 A newborn from this cohort presented with lissencephaly, cerebellar/cerebral hemorrhage, and hypoplasia/immaturity of the cerebellar cortex. Two individuals from the literature presented with lower limb muscle atrophy with no neuropathy identified at electromyography studies.25

Neurodevelopmental disorder

Developmental delay and/or intellectual disability are expected features in KAT6B disorders. Language disorders have been previously reported in 18% of individuals and were also noted in 19/32 (59%) of the individuals in this cohort.17,19,20,24,25,26,31,32,34,35 Of note, 5/19 (26%) children with speech difficulties in this cohort also had hearing impairment. Behavioral and/or psychiatric issues, such as features suggestive of autism spectrum disorder, anxiety, aggressive behavior, and attention problems have been noted previously in four individuals, but also in eight individuals in this report.13,19,25,34 Additionally, we report an individual where the pathogenic variant was inherited from an affected 34-year-old mother with reported learning disability, but no diagnosis of intellectual disability (individual 30). She lives independently, cares for her family, and works as a cashier. Mosaicism was not detected in the blood, and she was heterozygous for the deleterious variant.

Hearing impairment and ocular anomalies

Conductive or sensorineural hearing loss was present in 17% of individuals from the literature and in 7/32 (22%) of individuals from this cohort. External auditory canal malformations and/or stenosis, with or without hearing loss, were present in nine individuals from the literature.24,29,30,31,34,36

Visual deficits and various ocular anomalies are also frequent. Blepharophimosis, a major feature of SBBYSS that can impact visual function,23 was found in 23/32 (72%) of individuals in this cohort, and specifically in 14/15 (93%) of individuals with SBBYSS. Lacrimal duct anomalies (mainly dacryostenosis) were found in 15% and 6/32 (19%) of individuals from the literature and this cohort, respectively. Optic atrophy or hypoplasia have previously been reported in at least five individuals and were also observed in six individuals in this report.6,13,28,30 Some children also had early-onset visual problems such as myopia, hypermetropia, astigmatism, nystagmus, strabismus, amblyopia, and visual pursuit deficits.19,25,26,30,31,32,34 Telecanthus, epicanthus inversus, and hypertelorism are also sometimes noted.17,24,25,27,28,29,32,36,37

Craniofacial features

A distinctive facial appearance of blepharophimosis, ptosis, and/or mask-like facies characterizes most individuals with SBBYSS. Other features that can be common in both GPS and SBBYSS include low-set and posteriorly rotated ears, downslanting palpebral fissures, flat broad nasal bridge, tubular/bulbous nose, long philtrum, thin upper vermilion, and micro/retrognathia.

Cleft lip and palate and high-arched palate were present in 27% of published individuals and in 14/32 (44%) of individuals in this cohort. The uvula was reported to be bifid in five individuals from the literature and this cohort and absent in one individual in this cohort.25,30 Pierre Robin sequence was previously reported once and has also been observed in four individuals of this cohort.24

Dental anomalies such as delayed eruption of teeth and absent/hypoplastic teeth were previously seen in 36% of individuals and also in 8/32 (25%) of individuals in this cohort.

Affected individuals, including the ones in this report, also presented with other craniofacial anomalies such as sagittal craniosynostosis (two individuals), overriding skull bones (one individual), dolichocephaly (four individuals), and scaphocephalic skull shape (one individual).25,35,36

Genitourinary and renal anomalies

Genital anomalies were frequently present in all subtypes of KAT6B disorders, and 7/8 individuals with GPS in this cohort had genital anomalies. In males, this can include cryptorchidism, retractile testis, scrotal hypoplasia, micropenis, unilateral testicular agenesis, and hypospadias. In females, clitoromegaly and hypoplasia of the labia minora/majora are observed.5,6,7,17,24,25,29,30,36 One child with SBBYSS from this cohort had a bicornuate uterus.

Renal anomalies are more commonly observed in GPS, with hydronephrosis and multicystic kidneys being most common.6,7,13,26,27,30,36 Kim et al. reported a girl with GPS who had multicystic dysplastic kidneys leading to renal failure and pulmonary hypoplasia/hypertension.27 In this cohort, two newborns with GPS also presented with an oligohydramnios sequence due to bilateral renal hypoplasia or dysplasia. In addition, one individual had stage III bilateral vesicoureteral reflux with renal hypoplasia, one had unilateral ureteropelvic junction obstruction, and another had lower urinary tract obstruction with reflux and dysplastic cystic kidneys.

Gastrointestinal anomalies

Anal anomalies have been previously noted in six individuals, specifically anteriorly positioned anus and anal atresia or stenosis,6,26,33 and were also present in four individuals in this cohort. Intestinal malrotation, with potential fatal complications, has been reported previously in four individuals, and in two from this cohort.6,26,30 Feeding difficulties, gastroesophageal reflux, and/or recurrent emesis are frequent in affected individuals, and were present in nine individuals from this cohort.25,33 Chronic constipation has been previously reported in one individual and was also noted in four individuals in this series.17 Other reported findings include diaphragmatic eventration in one individual from this cohort and necrotizing enterocolitis in a 30-week premature newborn from the literature.36

Musculoskeletal features

Patellar anomalies, including agenesis, hypoplasia, delayed ossification, and displacement of the patella, were present in 8/32 (25%) of individuals in this cohort. Club feet and flexion contractures of the knees and/or hips are also frequently present (6/8 individuals with GPS in this cohort). Patellar anomalies and contractures both constitute major features of GPS. Contractures of the wrists or elbows were also found in three individuals in this cohort.

Long thumbs and/or long great toes are often observed in individuals with SBBYSS (in 12/15 [80%] in this cohort). Other digital anomalies were observed in 16% of previously reported individuals and in 12/32 (38%) of this cohort. These anomalies included preaxial or postaxial polydactyly, camptodactyly, clinodactyly, arachnodactyly, brachydactyly, overlapping fingers or toes, proximally implanted thumbs, and syndactyly of toes.13,17,19,24,25,26,29,31,32,34,36,37

Other musculoskeletal findings occasionally observed in the literature and in this cohort included kyphosis and scoliosis (6 individuals),6 thoracic anomalies such as pectus excavatum and narrow thorax (11 individuals),6,25,27,34,36 pelvic anomalies (6 individuals),6,7 and joint hypermobility (7 individuals).17,25,30,31,34 Other rarely reported features included hypoplastic heels,27 dolichostenomelia,24 coxa valga,25 genu valgum,17 femoral fracture and dislocated hips and knees,26 and exophytic lesions on the scapular spine.34

Cardiovascular anomalies

In this cohort, 15/32 (47%) of individuals had congenital heart defects, compared with 53% in previously reported individuals. These anomalies include mainly atrial and/or ventricular septal defects, patent foramen ovale, and patent ductus arteriosus.5,6,7,13,17,24,25,26,27,28,29,30,31,32,36,38 In this cohort, one individual had an abnormal aortic arch with a single left vertebral artery exiting between the left common carotid and left subclavian arteries as well as a retroesophageal right subclavian artery. Another individual had recurrent episodes of supraventricular tachycardia.

Growth and endocrine anomalies

Functional or structural thyroid abnormalities such as hypothyroidism and thyroid agenesis or hypoplasia are present in many affected individuals. Hypothyroidism was present in six individuals from this cohort. Growth retardation, short stature, failure to thrive/poor weight gain, and delayed bone age have also been reported in nine individuals from the literature and six from this cohort.13,26,29,30,31,35,36,39 Delayed puberty with primary amenorrhea has also been reported.26 Li et al. reported one individual with pituitary hypoplasia and severe growth hormone deficiency.39 One individual in this series had hyperphagia and obesity.

Respiratory findings

Respiratory distress exacerbated by tracheomalacia and/or laryngomalacia was present in 12/32 (38%) of individuals in this cohort and in 13% of individuals in the literature. Laryngeal cleft was previously reported in one individual.30 Central or obstructive sleep apnea was previously reported once13 but was noted in five individuals in this cohort.

Cutaneous findings

Cutaneous anomalies are infrequent. Among all individuals reported to date including this cohort, three had café-au-lait macules, one had cutaneous hemangiomas, six had abnormal palmar creases, five had widely spaced nipples, and four had hypoplastic nails.17,26,36,37 A webbed neck with redundant skin was observed in one individual but the result of the nuchal translucency was not specified.27

Prenatal findings

One child from this cohort had increased nuchal translucency prenatally and three had cystic hygroma, one of which was persistent into the second trimester. However, increased nuchal translucency and cystic hygroma have not been reported in individuals with KAT6B disorders in the literature. Kraft et al. reported an individual with a RASopathy-like phenotype with a chromosomal translocation disrupting the KAT6B gene.2 The result of the nuchal translucency scan was not specified. Additionally, in this cohort, two pregnancies were complicated by polyhydramnios, which has been previously reported in five individuals in the literature.25,32,35,36

Other findings

Knight et al. reported a child with GPS who developed a stage I neuroblastoma extending into the portal vein. While it was poorly differentiated, it had an overall favorable histopathology.33

One individual from this cohort had severe unexplained anemia at birth, poor intrahepatic hematopoiesis for gestational age on autopsy examination, and polysplenia.

Mortality

Kim et al. reported on a girl with GPS with early-onset seizures, multicystic dysplastic kidneys, renal failure, and pulmonary hypoplasia.27 She died at 8 months of age due to tracheostomy tube displacement. Gannon et al. reported a boy who was stillborn at 36 weeks of gestation and a girl who died from bronchiolitis at three years of age.30 In this cohort of 32 individuals, one pregnancy affected by GPS was medically terminated, one child with an intermediate phenotype died at 2 years of age, and three children with GPS died in infancy. The first infant died from pulmonary hypoplasia due to renal hypoplasia/dysplasia. The second, with multiple malformations including renal hypoplasia, also had severe anemia, and disseminated intravascular coagulation; she died shortly after birth at 28 weeks of gestation. The third died from influenza H1N1 infection at four months of age.

Update on pathogenic variants

We previously generated a LOVD database of all reported KAT6B pathogenic variants and have now updated it (Fig. 2). We report 24 novel variants, including 13 small intragenic deletions, 2 small intragenic duplications, and 9 single-nucleotide variants. These include the following types of variants at the protein level: 14 frameshift, 7 nonsense, 1 missense, and 2 intronic variants predicted to affect splicing. Most variants are located in exon 18, but one is in exon 4, seven in exon 16, and two in exon 17. The two splicing variants were located in introns 7 and 17. When parental samples were available, variants were de novo, with the exception of the splicing defect in intron 7 that was maternally inherited.

Fig. 2: Distribution of all pathogenic variants in KAT6B reported in literature (variants represented above the exons) and 24 new variants reported in this article (variants represented below the exons) with the associated phenotype(s).
figure 2

The variants c.5624_5625del/p.Ala1876Leufs*3 and c.5115_5116del/p.Tyr1706Ilefs*9 reported by Gannon et al.30 have not been included in this figure, because of discordance between the reported complementary DNA (cDNA) and expected protein change. GPS genitopatellar syndrome, NOS not otherwise specified, SSBYSS Say–Barber–Biesecker–Young–Simpson syndrome.

Full size image

Genotype–phenotype analysis

Variants leading to GPS occur within the proximal portion of exon 18, always between amino acids 1150 and 1515 in this cohort and the literature (Fig. 2). Variants within this region are associated with GPS in 60% of cases, SBBYSS in 19% of cases, and the intermediate phenotype in 19% of cases. Variants outside of this region cause SBBYSS and the intermediate phenotype in 84% and 13% of cases, respectively, and never cause GPS.

Variants associated with SBBYSS occur throughout the gene, but more often in exons 16–17 or distally in exon 18. In general, individuals with variants occurring in exons 1–16 tend to be more mildly affected, as observed in the three families with inherited variants, whereas individuals with variants occurring more distally seem to present with a more severe phenotype including more congenital anomalies. For instance, genitourinary anomalies and digital malformations are more frequent in individuals with variants in exons 17 and 18.

No variant reported in the literature or in our cohort has been associated with both GPS and SBBYSS. However, five variants have been reported so far both in individuals with GPS or SBBYSS and in individuals with an intermediate phenotype.

DISCUSSION

Our study has allowed further delineation of the clinical spectrum of KAT6B disorders. The description of additional individuals further challenges the original syndrome delineation and highlights that GPS, SBBYSS, and the intermediate phenotype are all part of a broad clinical spectrum. We are indeed moving toward naming these conditions as only KAT6B disorder in the future. However, clinicians still use the terms GPS and SBBYSS in their practice at the present time, so we thought it was premature to stop using them in this article. Moreover, we suspected it might still be clinically relevant to subdivide affected individuals into KAT6B disorder subtypes as they might present with different clinical outcomes, developmental impairment, cognitive profile, and medical complications. We have thus classified the individuals in this cohort into four different KAT6B disorder clinical subtypes and have suggested an approach to do so. More research is needed to address these questions. Nonetheless, this case series has highlighted that the major features previously defined by Campeau et al.23 remain the prominent clinical findings of KAT6B disorders, but also identified additional features that should raise clinical suspicion of this diagnosis and influence management.

In addition to abnormalities of the corpus callosum, almost half of affected individuals had other cerebral anomalies. A thorough neurological evaluation with a cerebral magnetic resonance image (MRI) and clinical surveillance for seizures is thus indicated in all individuals with suspicion of or a molecularly confirmed KAT6B disorder. Ocular anomalies and visual deficits were also found in many individuals with KAT6B disorders. Of note, optic nerve hypoplasia appeared to be more frequent than previously reported. This reinforces the importance of an ophthalmological evaluation. Additionally, periodic hearing examination should be performed as a significant proportion of affected individuals had sensorineural or conductive hearing loss. Intestinal malrotation has been described in several individuals and clinicians involved in the care of affected individuals should keep a high clinical suspicion for this. Currently, further evidence of utility is required to recommend screening by a barium enema study. We also highlight that some individuals presented with neurobehavioral problems suggestive of autism spectrum disorder. Screening and follow-up for these disorders with appropriate therapy should be considered. Again, we observe that hypothyroidism is frequent, thus periodic thyroid function testing is indicated. Finally, routine evaluation of individuals with suspected or confirmed KAT6B disorders should also include an echocardiogram and a renal ultrasound. The presence of contractures, mostly of the lower limbs, and other skeletal anomalies (including the spine) should be assessed by a clinical evaluation with X-rays and/or orthopedics consultation if needed.

We demonstrated that cystic hygroma can complicate the pregnancy of fetuses affected by KAT6B disorders. Thirteen percent of this cohort presented prenatally with an increased nuchal translucency or cystic hygroma. Interestingly, given the high frequency of Noonan syndrome in cohorts of fetuses with increased nuchal translucency and cystic hygroma,40 KAT6B haploinsufficiency was shown to upregulate the RAS-MAP kinase pathway (the pathway implicated in Noonan syndrome).2 We also confirmed that polyhydramnios is an associated anomaly. KAT6B disorders should thus be included in the differential diagnosis of these prenatal findings. Additionally, we identified two fetuses with severe renal anomalies leading to renal failure and four children with Pierre Robin sequence. One child with Pierre Robin sequence (individual 26) had initially been clinically diagnosed with Toriello–Carey syndrome, suggesting that when this syndrome is suspected, KAT6B disorders should also be considered in addition to the other genetic anomalies previously associated with Toriello–Carey syndrome (i.e., chromosomal anomalies and variants in PGAP3, DDX3X, and UBE3B).41 Digital anomalies, other than long thumbs and/or great toes, were also commonly observed. These included preaxial or postaxial polydactyly, camptodactyly, and brachydactyly. To date, the only neoplasm reported in an individual with a KAT6B disorder is a neuroblastoma. Although there might not be a direct relationship between KAT6B alteration and the development of this malignancy, it is interesting to note that a tumor suppressor role of KAT6B through histone H3 Lys23 acetyltransferase activity was suggested after observing KAT6B genomic loss in small cell lung cancer cell lines.42 Finally, we identified an individual with a maternally inherited variant, the third familial case of a molecularly confirmed KAT6B disorder reported so far. The proband’s mother presented an attenuated phenotype and was functioning at a higher level than most reported individuals. These findings expand the phenotypic spectrum of KAT6B disorders.

Our work provides a comprehensive review and expansion of the genotypic and phenotypic spectrum of KAT6B disorders that will assist clinicians in the assessment, counseling, and management of affected individuals. Research involving functional studies is required to investigate the hypothesized molecular mechanisms leading to KAT6B disorders.